Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

Artiva Biotherapeutics, Inc. insider trades

Artiva Biotherapeutics, Inc.'s insiders made 22 buys and 26 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

InsiderTradeSharesPriceValueDate
Aslan Fred
Director, Officer: Chief Executive Officer
Sale119,771USD 3.91US$469KNov 17, 2026
Banerjee Subhashis
Officer: Chief Medical Officer
Sale4,037USD 3.91US$15,792Nov 17, 2026
Bush Jennifer
Officer: COO, CLO, Compliance Officer
Sale19,217USD 3.91US$75,175Nov 17, 2026
Horan Christopher
Officer: Chief Tech Operations Officer
Sale20,546USD 3.91US$80,374Nov 17, 2026
Miralles Gines Diego
Officer: President & Head of R&D
Sale1,043USD 3.91US$4,080Nov 17, 2026
Aslan Fred
Director, Officer: Chief Executive Officer
Sale62,178USD 4.18US$260KNov 2, 2026
Banerjee Subhashis
Officer: Chief Medical Officer
Sale1,110USD 4.18US$4,641Nov 2, 2026
Bush Jennifer
Officer: COO, CLO, Compliance Officer
Sale8,439USD 4.18US$35,284Nov 2, 2026
Horan Christopher
Officer: Chief Tech Operations Officer
Sale10,423USD 4.18US$43,580Nov 2, 2026
Aslan Fred
Director, Officer: Chief Executive Officer
Sale23,463USD 7.20US$169KOct 6, 2026
Aslan Fred
Director, Officer: Chief Executive Officer
Sale61,696USD 6.84US$422KOct 5, 2026
Banerjee Subhashis
Officer: Chief Medical Officer
Sale1,099USD 6.84US$7,514Oct 5, 2026
Bush Jennifer
Officer: COO, CLO, Compliance Officer
Sale8,370USD 6.84US$57,227Oct 5, 2026
Horan Christopher
Officer: Chief Tech Operations Officer
Sale10,340USD 6.84US$70,697Oct 5, 2026
Aslan Fred
Director, Officer: Chief Executive Officer
Sale23,429USD 10.92US$256KSep 8, 2026
Aslan Fred
Director, Officer: Chief Executive Officer
Sale61,888USD 11.16US$691KSep 3, 2026
Banerjee Subhashis
Officer: Chief Medical Officer
Sale1,100USD 11.16US$12,276Sep 3, 2026
Bush Jennifer
Officer: COO, CLO, Compliance Officer
Sale8,391USD 11.16US$93,644Sep 3, 2026
Horan Christopher
Officer: Chief Tech Operations Officer
Sale10,366USD 11.16US$116KSep 3, 2026
Banerjee Subhashis
Officer: Chief Medical Officer
Sale8,222USD 12.01US$98,746Aug 27, 2026
Banerjee Subhashis
Officer: Chief Medical Officer
Sale429USD 12.00US$5,148Aug 18, 2026
RA Capital Healthcare Fund LP
Director, 10% owner
Buy24,944USD 9.93US$248KJul 31, 2026
RA Capital Healthcare Fund LP
Director, 10% owner
Buy20,824USD 9.99US$208KJul 29, 2026
RA Capital Nexus Fund III, L.P.
Director
Buy41,319USD 9.99US$413KJul 24, 2026
Kolchinsky Peter
Director, 10% owner
Buy59,880USD 9.96US$596KJul 23, 2026
Kolchinsky Peter
Director, 10% owner
Buy84,124USD 9.93US$835KJul 22, 2026
Kolchinsky Peter
Director, 10% owner
Buy120,582USD 9.55US$1.15MJul 21, 2026
RA Capital Healthcare Fund LP
Director, 10% owner
Buy7,882USD 8.95US$70,544Jul 17, 2026
RA Capital Healthcare Fund LP
Director, 10% owner
Buy152,472USD 8.93US$1.36MJul 16, 2026
RA Capital Nexus Fund, L.P.
Director
Buy6,522USD 8.94US$58,307Jul 13, 2026
Shah Rajeev M.
Director, 10% owner
Buy6,552USD 8.94US$58,575Jul 13, 2026
Shah Rajeev M.
Director, 10% owner
Buy15,102USD 8.97US$135KJul 10, 2026
Ra Capital Management, L.P.
Director, 10% owner
Buy1,876USD 8.98US$16,846Jun 26, 2026
Ra Capital Management, L.P.
Director, 10% owner
Buy31,000USD 8.88US$275KJun 25, 2026
Kolchinsky Peter
Director, 10% owner
Buy124,893USD 8.89US$1.11MJun 16, 2026
Kolchinsky Peter
Director, 10% owner
Buy15,414USD 8.99US$139KJun 15, 2026
Kolchinsky Peter
Director, 10% owner
Buy391,019USD 8.57US$3.35MJun 12, 2026
RA Capital Nexus Fund, L.P.
Director
Buy548,580USD 7.91US$4.34MJun 11, 2026
RA Capital Nexus Fund, L.P.
Director
Buy103USD 7.00US$721Jun 10, 2026
RA Capital Nexus Fund, L.P.
Director
Buy479,039USD 6.91US$3.31MJun 9, 2026
Aslan Fred
Director, Officer: Chief Executive Officer
Sale27,116USD 9.01US$244KMay 19, 2026
Banerjee Subhashis
Officer: Chief Medical Officer
Sale7,037USD 9.01US$63,403May 19, 2026
Bush Jennifer
Officer: COO, CLO, Compliance Officer
Sale8,790USD 9.01US$79,198May 19, 2026
Horan Christopher
Officer: Chief Tech Operations Officer
Sale7,002USD 9.01US$63,088May 19, 2026
Raymon Heather
Officer: SVP, Research and Development
Sale3,095USD 9.01US$27,886May 19, 2026
GC Corp
10% owner
Buy1,085,069USD 11.52US$12.5MMay 11, 2026
GC Corp
10% owner
Buy347,222USD 11.52US$4MMay 11, 2026
RA Capital Nexus Fund III, L.P.
Director
Buy6,510,416USD 11.52US$75MMay 11, 2026

Artiva Biotherapeutics, Inc. shareholders